Development and Validation of an UPLC-MS/MS Method for Pharmacokinetic Comparison of Five Alkaloids from JinQi Jiangtang Tablets and Its Monarch Drug Coptidis Rhizoma

Author： Sun Lili   Ding Feifei   You Guangjiao   Liu Han   Wang Meng   Ren Xiaoliang   Deng Yanru  

Publisher： MDPI

E-ISSN： 1999-4923|10|1|4-4

ISSN： 1999-4923

Source： Pharmaceutics, Vol.10, Iss.1, 2017-12, pp. : 4-4

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development and Validation of a UPLC-MS/MS and UPLC-HR-MS Method for the Determination of Fumonisin B1 and Its Hydrolysed Metabolites and Fumonisin B2 in Broiler Chicken Plasma

By De Baere Siegrid   Croubels Siska   Novak Barbara   Bichl Gerlinde   Antonissen Gunther  

Toxins, Vol. 10, Iss. 2, 2018-01 ,pp. : 62-62

MDPI

Access to resources Recommend Favorite

Pharmacokinetics of Dibutyl Phthalate (DBP) in the Rat Determined by UPLC-MS/MS

By Chang Li-Wen   Hou Mei-Ling   Tsai Tung-Hu  

International Journal of Molecular Sciences, Vol. 14, Iss. 1, 2013-01 ,pp. : 836-849

MDPI

Access to resources Recommend Favorite

Automatic Supported Liquid Extraction (SLE) Coupled with HILIC-MS/MS: An Application to Method Development and Validation of Erlotinib in Human Plasma

By Pan Jiongwei   Jiang Xiangyu   Chen Yu-Luan  

Pharmaceutics, Vol. 2, Iss. 2, 2010-04 ,pp. : 105-118

MDPI

Access to resources Recommend Favorite

Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149

By Boelaert Jente   Schepers Eva   Glorieux Griet   Eloot Sunny   Vanholder Raymond   Lynen Frédéric  

Toxins, Vol. 8, Iss. 11, 2016-10 ,pp. : 312-312

MDPI

Access to resources Recommend Favorite

Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149

By Tsikas Dimitrios   Beckmann Bibiana   Araujo Pedro  

Toxins, Vol. 8, Iss. 11, 2016-10 ,pp. : 311-311

MDPI

Access to resources Recommend Favorite